A giant submandibular sialolith - How to manage?

The presence of a sialolith is one of the most common diseases of salivary gland. It is relatively common in submandibular salivary glands and its duct. This case report is of a patient who presented at our unit with a history of severe pain and swelling on floor of the mouth, which was clinically and radiographically diagnosed as a sialolith. The diagnostic and treatment protocol in managing a patient with a giant sialolith is enumerated in this manuscript

Efficient Portfolios Versus Efficient Market

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108275/1/jfir00282.pd

Evidence That The Common Stock Market Adjusts Fully For Expected Inflation

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108367/1/jfir00022.pd

A COMPARATIVE STUDY IN THE DIABETES MELLITUS PATIENTS FOR ORAL MANIFESTATION AT TERTIARY CARE HOSPITAL IN NORTH KARNATAKA

ABSTRACTObjective: Diabetes mellitus is the leading health problem across the world. It is associated with several complications such as retinopathy, neuropathy,oral manifestations, chronic macrovascular and microvascular complications. Our objective is to compare these oral manifestations in controlled anduncontrolled diabetic patients.Methods: A study was conducted on total of 100 diabetic patients. The patients were divided into two groups: Group I (n=50) consists of controlleddiabetic patients and Group II (n=50) consists of uncontrolled diabetic patients. Before, the start of the study proper oral examination was donefor both the groups. Samples were collected and were subjected to microbial examination. Comparison between both the groups was done for oralmanifestations.Results: It showed that uncontrolled diabetic patients had a higher incidence of oral manifestations such as hyposalivation, parotid enlargement,burning sensation of mouth, taste alterations, sialorrhea, dental carries, and microbial lesions than controlled diabetes patients.Conclusion: Uncontrolled diabetic patients had higher risk of oral manifestations than controlled diabetic individuals.Keywords: Diabetes mellitus, Retinopathy, Neuropathy, Oral manifestations, Periodontitis, Hyposalivation

ROBO-CALLING PREVENTION WITH SOFTWARE-DEFINED NETWORKING IN A WIDE AREA NETWORK POLICY FOR UNIFIED COMMUNICATION

Techniques are described herein for blocking robo-calls, spam calls, and telemarketing calls, which are becoming an industry menace. Such calls are blocked by tightly integrating a Software-Defined Networking in a Wide Area Network (SDWAN) controller with a Do Not Call registry. Analytics are used to analyze traffic call patterns, security insights are leveraged such as known malicious Internet Protocol (IP) and domain addresses, and a Call Barring feature may also be applied. This information may be pushed to edge devices to ensure robo-calls do not terminate on SDWAN-led voice endpoints

Viewing Spatial Consequences of Budgetary Policy Changes

While the research community is often very concerned with the distributional effect of public policy decisions, the geographic distribution of the affected populations is often overlooked. This paper argues that seemingly geographically neutral policies have spatial consequences and that the choice of how to measure them is important. We suggest that maps produced by geographical information systems (GIS) provide a powerful tool for communicating these ideas to policy makers. We further suggest that GIS supplemented by spatial statistics yield geographic information that can perform a valuable function in policy debates. We use the recent proposed changes in Medicaid expenditures in Ohio to illustrate how geographic information provides insights into the spatial consequences of these changes by introducing a simple method to weight the impact of expenditure changes.This study was supported, in part, by funding from The Health Foundation of Greater Cincinnati

ASSESSMENT OF PREVALENCE OF DEPRESSION IN CARDIAC PATIENTS AND ITS ASSOCIATION WITH THE USE OF BETA-BLOCKERS AND STATINS

Objective: The objective of the study is to assess the prevalence of depression among patients with cardiovascular disease and its association with the use of β-blockers and statins.Methods: This is a prospective observational study conducted at a corporate hospital, Hyderabad, Telangana, India, for a period of 6 months. 250 cardiac patients above 16 years are included in the study. The required data are collected from the patients through direct interview using standard questionnaires and also from patients' respective case sheets. The acquired data are evaluated based on the standard questionnaires Patient Health Questionnaire-9 (PHQ-9) and Beck Depression Inventory-II (BDI-II) scales; used to diagnose the severity of depression in cardiac patients.Results: Prevalence of minor to major depressive symptoms according to BDI-II was found to be 17.2%. Prevalence of minor to major depressive symptoms according to PHQ-9 was found to be 19.2%. Among male patients, 13% showed depressive symptoms, whereas among female patients 25% showed depressive symptoms. Among the patients coadministering beta-blockers and statins, 15% were depressed according to BDI-II, and 16% were depressed according to PHQ-9 at visit. After 1 month (first follow-up), the percentage increased by 8% (for BDI-II)-12% (for PHQ-9) and remains almost the same at the second follow-up. As per BDI-II and PHQ-9 scores, the percentage of patients with minor to major depression among the patients using only beta-blockers decreased significantly from the time of visit to the second follow-up. The percentage of patients with minor to major depression among the patients using only statins increased significantly from the time of visit to second follow-up.Conclusion: Prevalence of minor to major depression according to BDI-II was found to be 17%, whereas according to PHQ-9, it was found to be 20% in patients with cardiovascular disease. Cardiovascular diseases have been more prevalent in men than in women, whereas depressive symptoms have been more prevalent in women than in men. Patients using only β-blockers showed a decrease in symptoms of depression. Whereas statins have shown to increase the chances of depression slightly which is often negligible, atorvastatin was associated with a higher level of depression when compared to rosuvastatin. Controversies still exist that statins decrease risk of depression.Â